Zentiva S.A. (BVB: SCD)

Market Cap	2.83B
Revenue (ttm)	1.05B
Net Income (ttm)	263.29M
Shares Out	697.02M
EPS (ttm)	0.38
PE Ratio	10.75
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,656
Open	4.040
Previous Close	4.040
Day's Range	4.040 - 4.100
52-Week Range	2.280 - 4.600
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 10, 2024

About Zentiva

Zentiva S.A. engages in the production and marketing of preparations and medicines for human use in Romania and internationally. The company develops pharmaceutical products in various therapeutic areas, such as cardiovascular diseases, anti-inflammatory and pain-relieving medications, urologists, blood diseases, gastrointestinal and metabolic disorders, central nervous system, infections, respiratory systems, and other. It also offers educational materials for healthcare professionals and patients. The company was formerly known as Sicomed S.A...

• Industry: Pharmaceutical Preparations
• Founded: 1962
• Employees: 1,035
• Stock Exchange: Bucharest Stock Exchange
• Ticker Symbol: SCD

Financial Performance

In 2023, Zentiva's revenue was 953.63 million, an increase of 25.54% compared to the previous year's 759.63 million. Earnings were 192.62 million, an increase of 93.65%.